Ownership
Private
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved

RevHealth General Information

RevHealth does not conduct clinical trials or have clinical results. It provides omnichannel healthcare communications and strategic brand consulting for pharmaceutical, biotech, and medical device companies. The company has launched AgencyOS in partnership with PixieDust Labs to optimize campaign development using AI. It has been recognized as one of the top independent agencies in North America for its creative expertise and industry impact. In July 2022, WindRose Health Investors recapitalized the business to support further growth; founders remain significant shareholders and continue leading the company. Recent leadership changes include Ben Beckley as CEO since 2024. The firm partners with clients across all stages of product lifecycle marketing—from pre-launch strategy through post-market education—helping communicate cutting-edge science and launch novel therapies.

Contact Information

Primary Industry
Consulting
Corporate Office
Morristown, New Jersey
United States

Drug Pipeline

No pipeline data available

For full access to RevHealth's pipeline data

Book a demo

Key Partnerships

PixieDust Labs

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

RevHealth Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view RevHealth's complete valuation and funding history, request access »

RevHealth Financial Metrics